Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RLYB

Rallybio Corp

CIK 0001739410 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$16.83
↑ 0.23 (1.39%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$89.38M
P/E Ratio
1.96
EPS
-1.59
Dividend Yield
Not covered
52W Position
96%
Beta
0.89

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.95
P/S
138.35
EV/Revenue
-5.38
ROE
48.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 96%
$0.48$17.57

Latest Financials

2025-12-31 FY
Revenue
$858.00K
Net Income
-$8.98M
Total Assets
$62.26M
Free Cash Flow
–

Recent news